,

Johann Poetzl1

  • 1Clinical Development Biopharmaceuticals, Hexal AG (A Sandoz company), Holzkirchen, Germany.

Bioanalysis
|February 4, 2025
PubMed
概括

免疫性评估的进步为生物类似物开发提供了新的策略. 将免疫性风险评估纳入许可申请,有助于监管审查,并证明生物相似性.